KCAS Bio will be attending the EUROTOX Congress 2025, scheduled for September 14-17 in Athens, Greece. Organized by the Federation of European Toxicologists and European Societies of Toxicology, this event will bring together leading experts and emerging scientists to explore practical approaches to sustainable health and well-being.
The gathering will showcase keynote presentations and emerging voices in the field, focusing on innovative technologies and methodologies, and significant scientific advancements in toxicology.
KCAS Bio’s Role in Toxicology
KCAS Bio is committed to contributing to ongoing advancements in toxicology. Through the generation of high-quality bioanalytical and biomarker data, we support safety assessments aimed at identifying and mitigating toxicity throughout the drug development process. Our core services in toxicology support include bioanalytical and biomarker assays, immunogenicity testing, dose formulation analysis, and advanced cellular assays such as spectral flow cytometry. As toxicology continues to evolve alongside new therapeutic modalities and regulatory expectations, KCAS Bio remains closely engaged with the field’s progress to ensure our methods and insights align with the latest scientific and technological developments.
Let’s Connect at the EUROTOX Congress 2025
We invite you to connect with Jeff Goddard throughout the meeting days. Jeff will be present to discuss any and all elements of your project plans. He is looking forward to engaging in conversation about how KCAS Bio can help meet your project needs and goals.